PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
Clinical trial NCT05154162 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05154162
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-02
- Primary completion
- 2025-12-15
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.